| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |